HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HCWB is expected to report earnings to fall 154.05% to -120 cents per share on August 07
Q2'26
Est.
$-1.20
Q1'26
Beat
by $17.82
Q4'25
Beat
by $1.41
Q3'25
Beat
by $0.28
Q2'25
Missed
by $2.70
The last earnings report on May 14 showed earnings per share of $2.22, beating the estimate of -1560 cents. With 9.34K shares outstanding, the current market capitalization sits at 7.27M.